Pancreatic Cancer Research

ResearcherUniversity of Colorado AnschutzActive in the last 2 years

Gagan Deep

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4445-8796; OpenAlex author ID A5013529371, A5059572873. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Molecular Characterization of Small Extracellular Vesicles in Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy Followed by Stereotactic Body Ra… Last author DOI 10.3390/cancers18111704↗
  2. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. First author DOI 10.1002/mc.22833↗
  3. Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells. First author DOI 10.3892/ijo.2015.2885↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Upender Manne Manne · 1 shared paper, 2026 · strength 0.32
  2. Olumide B. Gbolahan · 1 shared paper, 2026 · strength 0.32
  3. Ashish Manne · 1 shared paper, 2026 · strength 0.32
  4. Ravi Kumar Paluri · 1 shared paper, 2026 · strength 0.32
  5. Rajesh Agarwal · 2 shared papers, 2015–2018 · strength 0.15
  6. Deepanshi Dhar · 1 shared paper, 2018 · strength 0.09
  7. Ranganatha R. Somasagara · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.